In vivo, in vitro, and molecular docking study of rat pancreatic lipase inhibition using isopropyl salicylate
The Ukrainian Biochemical Journal · 15.09.2025 · 97 (4) · 84-93
DOI: 10.15407/ubj97.04.084 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Ukrainian Biochemical Journal, online erschienen am 15.09.2025. Verfasst von Noor M. Mahdi und 3 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 48 Literaturangaben.
Abstract (Originalsprache)
Pancreatic lipase (PL) represents a significant treatment target that has been the focus of research on anti-obesity medications. Orlistat is the only regularly used prescription that has been approved for long-term use. The discovery of new compounds for anti-obesity treatment based on PL inhibition can be achieved, in particular, by structure-based virtual screening with docking software. The aim of this research was to study isopropyl salicylate (IPS) anti-hyperlipidemic activity and inhibitory effect on rat pancreatic PL in comparison with orlistat. Wistar rats were divided into four groups of 8 animals each: control; fed with a high-fat diet (HFD) for 12 weeks to produce hyperlipidemia; fed with HFD and Orlistat (10 mg/kg BW daily); fed with HFD and IPS (10.81 mg/kg BW daily). It was shown that BW gain and lipase activity in the plasma of the high-fat diet rats treated with either orlistat or isopropyl salicylate were reduced considerably compared with untreated rats. The pancreatic lipase was partially purified from the plasma of obese rats, and a kinetic study of the IPS effect identified a competitive inhibition mode with an assessed Ki of 30.53 mM. An in silico study of the interaction between IPS and rat pancreatic lipase-related protein 2 (PDB ID: 1BU8) was conducted. The binding energy value ΔG for the IPS-protein complex at the enzyme’s active site was found to be -5.4 kcal/mol, while that for the orlistat-protein complex was -4.4 kcal/mol, indicating the stronger interaction of the enzyme with isopropyl salicylate than with orlistat. Keywords: in silico study, inhibition, isopropyl salicylate, obesity, orlistat, pancreatic lipase, rat pancreatic lipase-related protein 2
Zitieren
APA
Mahdi, N. M., Younus, S. A., Al-Burgus, A. F., & Al-Abbasy, O. Y. (2025). In vivo, in vitro, and molecular docking study of rat pancreatic lipase inhibition using isopropyl salicylate. The Ukrainian Biochemical Journal, 97(4), 84-93. https://doi.org/10.15407/ubj97.04.084
Vancouver
Mahdi NM, Younus SA, Al-Burgus AF, Al-Abbasy OY. In vivo, in vitro, and molecular docking study of rat pancreatic lipase inhibition using isopropyl salicylate. The Ukrainian Biochemical Journal. 2025;97(4):84-93. doi:10.15407/ubj97.04.084
BibTeX
@article{Mahdi2025,
author = {Mahdi, Noor M. and Younus, Sarah A. and Al-Burgus, Abdallah F. and Al-Abbasy, Omar Y.},
title = {In vivo, in vitro, and molecular docking study of rat pancreatic lipase inhibition using isopropyl salicylate},
journal = {The Ukrainian Biochemical Journal},
year = {2025},
volume = {97},
number = {4},
pages = {84--93},
doi = {10.15407/ubj97.04.084}
}
EUVIMED